Virus‐like particles for vaccination against cancer
<p dir="ltr">Active immunotherapy of cancer aims to treat the disease by inducing effective cellular and humoral immune responses. Virus‐like particle‐based vaccines have evolved dramatically over the last few decades, greatly reducing morbidity and mortality of several infectious di...
Saved in:
| Main Author: | Mona O. Mohsen (4056964) (author) |
|---|---|
| Other Authors: | Daniel E. Speiser (8262588) (author), Alexander Knuth (11104) (author), Martin F. Bachmann (7116422) (author) |
| Published: |
2019
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The <i>3Ds</i> in virus‐like particle based‐vaccines: “<i>Design, Delivery and Dynamics</i>”
by: Mona O. Mohsen (4056964)
Published: (2020) -
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
by: Mona O. Mohsen (4056964)
Published: (2019) -
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
by: Mona O. Mohsen (4056964)
Published: (2019) -
The impact of size on particle drainage dynamics and antibody response
by: Simon Zinkhan (14214245)
Published: (2021) -
Role of Epstein–Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target
by: Queenie Fernandes (14557388)
Published: (2018)